Related Experiment Video
Updated: Jun 24, 2025
08:29
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
10.0K
Bioinspired cellular membrane-derived vesicles for mRNA delivery
Xiao Xu1, Limei Xu1, Jingzhi Wang1
1Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, China.
Theranostics
|June 10, 2024
Summary
Messenger RNA (mRNA) therapeutics show promise for diseases. Natural cell-derived vesicles offer a safe and effective platform for mRNA delivery, enhancing drug capabilities and immune evasion.
Area of Science:
- Biomedical Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Messenger RNA (mRNA) has advanced rapidly as a vaccine and therapeutic agent.
- Effective clinical application of mRNA therapeutics relies heavily on suitable delivery carriers.
- Natural cell-derived vesicles are emerging as a promising nanovesicle platform for mRNA delivery.
Purpose of the Study:
- To summarize the characteristics and properties of biomimetic delivery systems for mRNA therapeutics.
- To discuss the unique features of cellular membrane-derived vesicles (CDVs).
- To explore the combination of synthetic nanovesicles with CDVs for enhanced mRNA delivery.
Main Methods:
- Review and summarization of existing literature on biomimetic delivery systems.
- Analysis of the properties and functions of cellular membrane-derived vesicles (CDVs).
- Investigation into hybrid systems combining synthetic nanovesicles with CDVs.
Main Results:
- Cell-derived vesicles (CDVs) offer enhanced drug delivery capabilities.
- CDVs provide immune evasion, crucial for safe and effective mRNA therapeutics.
- Combining synthetic nanovesicles with CDVs presents a unique platform for mRNA delivery.
Conclusions:
- Biomimetic delivery systems, particularly CDVs, are a promising avenue for mRNA therapeutics.
- The unique properties of CDVs enhance the safety and efficacy of mRNA delivery.
- Hybrid systems integrating synthetic nanovesicles with CDVs warrant further investigation for advanced therapeutic applications.
More Related Videos
Related Concept Videos
02:22Regulated mRNA Transport
6.3K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
6.3K
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
02:30siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K